Veradermics MANE
NYSE MANE
$148.63 +4.88 (+3.39%)
At close: Nov 10, 2026 · 4:00 PM EST

Veradermics (MANE) Change in Cash (2025 - 2026)

Updated

Veradermics' Change in Cash was $150.92 million in Q2 2026, compared with -$23.84 million a year earlier and up 2.9% from the prior quarter.

Analysis

Veradermics (MANE) Change in Cash (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Veradermics' Change in Cash was $253.08 million through Jun 30, 2026; for FY2025, it came in at -$31.32 million.

  • In earlier years, Change in Cash was $36.79 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -4.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -3.51 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.21 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.76 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 3.04 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -799.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 3.26 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 845.00 Mn
10 Veradermics 822.06 Mn -1.33 Bn - -187.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -187.18 Mn
Jun 30, 2026 150.92 Mn
Mar 31, 2026 146.65 Mn
Dec 31, 2025 16.11 Mn
Sep 30, 2025 -2.94 Mn
Jun 30, 2025 -23.84 Mn
Mar 31, 2025 -20.64 Mn
API Access

Veradermics Change in Cash API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-cash&ticker=MANE&period=max&api_key=YOUR_API_KEY